Pharma Pulse 3/20/24: The Unbearable Vagueness of Medical ‘Professionalism’, Care Patient Clinic Addresses Common Barriers to Care & more

Access USA 2024: The State of the Industry

Informa’s Access USA Conference from Philadelphia—featuring Patient Assistance & Access Programs (PAP) and Hub and Specialty Models East—opening session addresses the evolving landscape of healthcare coverage and accessibility.

The Care Patient Clinic Addresses Common Barriers to Care

Zac Donehue, PharmD, the director of Care Partner Operations at Allegheny Health Network, Pittsburgh, Pennsylvania, and David Jordan, PharmD, a clinical pharmacy specialist at Allegheny Health Network, join Pharmacy Times to discuss the Network’s new Care Partner Clinic (CPC), a pharmacist-run ambulatory clinic that focuses on optimizing patient health, especially the health of patients with chronic diseases, from the cost and clinical perspective. They dive into unmet patient needs, medication management, and the impact of the pharmacist on patient outcomes.

The Unbearable Vagueness of Medical ‘Professionalism’

Since its inception, this murky term has straddled the dual role of disciplining and inspiring.

Takeda Announces FDA Approval of Supplemental New Drug Application for ICLUSIG in Adult Patients with Newly Diagnosed Ph+ ALL

Takeda announced that the U.S. Food and Drug Administration has approved the supplemental New Drug Application for ICLUSIG® (ponatinib) for the treatment of adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy.

From FDA Oncology on X:

Colorectal cancer is the third most common cancer in both men and women, yet it is the most preventable. This #ColorectalCancerAwarenessMonth, let's raise awareness about the importance of early screening.

#OCEProjectCommunity #CancerAwareness

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs